Prediction: Berkshire Hathaway Stock Tops $700 a Share Before the End of 2030

The article projects Berkshire Hathaway’s B shares could reach at least $700 by the end of 2030, roughly 30% above their present price, based on a potential $1.5 trillion valuation. It assumes operating earnings reach at least $60 billion, the equity portfolio grows from $362 billion to about $475 billion at a 7% annual return, and cash remains near $400 billion; this is a conditional projection, not a company forecast.

Analysis

The bullish case is less about portfolio appreciation than whether Berkshire can convert its unusually large liquidity reserve into durable per-share earnings. That creates an asymmetric execution test for Greg Abel: disciplined buybacks or attractive acquisitions could improve capital efficiency, while deploying cash merely to appear active could dilute returns. Conversely, if short rates decline, the reserve’s income contribution may fade before operating businesses replace it; this is a near-term earnings sensitivity the long-dated projection does not make explicit.

The valuation claim also needs a sum-of-the-parts check. Operating earnings, the equity portfolio and cash are not independent pieces if investment income is embedded in earnings, and the article does not specify the multiple applied to operating businesses or adjust for insurance liabilities and other corporate claims. Treat the stated endpoint as a scenario, not an independently established fair value. Even if achieved, the cited upside over several years is not, by itself, compelling compensation for transition and allocation risk.

Days: the article’s optimism may support sentiment, but does not establish a fresh catalyst. Over 1–3 months, watch reported operating earnings by business, insurance underwriting, cash deployment and repurchases; distinguish recurring operating performance from investment gains. Over 6–18 months, Abel’s capital-allocation record and reserve yield sensitivity matter more than the headline portfolio return assumption. Contrarian risk: investors may over-credit Buffett-era discipline as automatically transferable, while underestimating the option value of waiting for better opportunities. The thesis weakens if operating earnings stagnate, underwriting deteriorates, or capital is deployed at returns below Berkshire’s alternatives.

Key Decisions for Investors

• No trade solely on the projected share-price endpoint; the article’s assumptions do not establish an attractive entry valuation. Treat BRK.A as a watchlist/core-quality candidate rather than a near-term catalyst trade.
• For existing exposure, retain the position only while operating earnings remain supported by underlying business performance and insurance underwriting; reassess after the next earnings release for investment-income versus operating trends.
• Set an alert for evidence of material buybacks, acquisitions, or a sustained change in cash levels. Evaluate each against per-share value creation, not deployment volume; absent transaction terms and return data, do not pre-commit to a positive reaction.
• Falsifiers: consecutive deterioration in operating earnings or insurance results, meaningful cash-yield compression without offsetting operating growth, or capital allocation that fails to improve per-share economics. A broad-market rally alone would not validate the thesis.